Vérification…
Traduit automatiquement. Doses et mises en garde : vérifiez l'original en anglais. Lire en anglais
Accueil / Enregistré au Nigeria / Bleormine Tablet

Bleormine Tablet

NAFDAC REG NO: B4-5620 Médicament

Enregistré auprès de NAFDAC. Enregistrement actifAs of 29 October 2026 · synced automatically from official sources.
Produit
Bleormine Tablet
Numéro NAFDAC
B4-5620
Principe actif
Promethazine Teoclate
Dosage
25 mg
Forme
Tablet
Conditionnement
1 x 20's (in PVC-Alu blister)
Fabricant
Non répertorié
Déposant / Titulaire :
Teka Pharmaceutical Co. Ltd
Approuvé
2 Mar 2021
Statut
Inactive Vue sur NAFDAC ↗
Enregistrement valable jusqu'au
1 Mar 2026
Alertes OMS
Non trouvé
Community reports
None
Times checked
0

About the medicine: Promethazine teoclate: uses, dosage and brands worldwide

What we found

  • Bleormine Tablet is on the NAFDAC register with an active registration (B4-5620). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Bleormine Tablet

Ce que dit la notice officielle. Si un médecin vous l'a prescrit, suivez l'ordonnance. La notice de votre boîte prime si elle est différente.

Pour qui

Promethazine hydrochloride tablets, USP are useful for: Perennial and seasonal allergic rhinitis. Vasomotor rhinitis. Allergic conjunctivitis due to inhalant allergens and foods. Mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Amelioration of allergic reactions to blood or plasma. Dermographism. Anaphylactic reactions, as adjunctive therapy to epinephrine and other standard measures, after the acute manifestations have been controlled. Preoperative, postoperative, or obstetric sedation. Prevention and control of nausea and vomiting associated with certain types of anesthesia and surgery. …

Comment le prendre et à quelle fréquence
  • Promethazine hydrochloride tablets, USP are contraindicated for children under 2 years of age (see WARNINGS - Black Box Warning and Use
  • In Pediatric Patients )
  • Promethazine hydrochloride tablets, USP are for oral administration only
  • Allergy The average oral dose is 25 mg taken before retiring; however, 12.5 mg may be taken before meals and on retiring, if necessary
  • Single 25 mg doses at bedtime or 6.25 mg to 12.5 mg taken three times daily will usually suffice
  • After initiation of treatment in children or adults, dosage should be adjusted to the smallest amount adequate to relieve symptoms
  • The administration of promethazine hydrochloride in 25 mg doses will control minor transfusion reactions of an allergic nature
  • Motion Sickness The average adult dose is 25 mg taken twice daily
  • The initial dose should be taken one-half to one hour before anticipated travel and be repeated 8 to 12 hours later, if necessary
  • On succeeding days of travel, it is recommended that 25 mg be given on arising and again before the evening meal
  • For children, promethazine hydrochloride tablets, USP 12.5 mg to 25 mg, twice daily, may be administered
  • Nausea and Vomiting Antiemetics should not be used in vomiting of unknown etiology in children and adolescents (see WARNINGS - Use
  • In Pediatric Patients )
  • The average effective dose of promethazine hydrochloride tablets, USP for the active therapy of nausea and vomiting in children or adults is 25 mg. 12.5 to 25 mg doses may be repeated, as necessary, at 4 to 6 hour intervals. …
Talk to a doctor first if
  • Promethazine hydrochloride tablets, USP are contraindicated for use
  • In pediatric patients less than two years of age
  • Promethazine hydrochloride tablets, USP are contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines
  • Antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms including asthma
Warnings

WARNING: PROMETHAZINE HYDROCHLORIDE TABLETS, USP SHOULD NOT BE USED IN PEDIATRIC PATIENTS LESS THAN 2 YEARS OF AGE BECAUSE OF THE POTENTIAL FOR FATAL RESPIRATORY DEPRESSION. POSTMARKETING CASES OF RESPIRATORY DEPRESSION, INCLUDING FATALITIES, HAVE BEEN REPORTED WITH USE OF PROMETHAZINE HYDROCHLORIDE TABLETS, USP IN PEDIATRIC PATIENTS LESS THAN 2 YEARS OF AGE. A WIDE RANGE OF WEIGHT-BASED DOSES OF PROMETHAZINE HYDROCHLORIDE TABLETS, USP HAVE RESULTED IN RESPIRATORY DEPRESSION IN THESE PATIENTS. CAUTION SHOULD BE EXERCISED WHEN ADMINISTERING PROMETHAZINE HYDROCHLORIDE TABLETS, USP TO PEDIATRIC PATIENTS 2 YEARS OF AGE AND OLDER. …

Effets secondaires possibles

Central Nervous System Drowsiness is the most prominent CNS effect of this drug. Sedation, somnolence, blurred vision, dizziness; confusion, disorientation, and extrapyramidal symptoms such as oculogyric crisis, torticollis, and tongue protrusion; lassitude, tinnitus, incoordination, fatigue, euphoria, nervousness, diplopia, insomnia, tremors, convulsive seizures, excitation, catatonic-like states, hysteria. Hallucinations have also been reported. Cardiovascular — Increased or decreased blood pressure, tachycardia, bradycardia, faintness. Dermatologic — Dermatitis, photosensitivity, urticaria. Hematologic — Leukopenia, thrombocytopenia, thrombocytopenic purpura, agranulocytosis. …

If you take too much

Signs and symptoms of overdosage with promethazine hydrochloride range from mild depression of the central nervous system and cardiovascular system to profound hypotension, respiratory depression, unconsciousness, and sudden death. Other reported reactions include hyperreflexia, hypertonia, ataxia, athetosis, and extensorplantar reflexes (Babinski reflex). Stimulation may be evident, especially in children and geriatric patients. Convulsions may rarely occur. …

En cas d'oubli

Prenez-le dès que vous y pensez, sauf s'il est presque l'heure de la dose suivante. Dans ce cas, sautez la dose oubliée. Ne prenez jamais deux doses à la fois pour compenser. Vérifiez votre notice, certains médicaments font exception.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2022-10-08.

Label for promethazine teoclate, the active ingredient registered with NAFDAC.

Check your pack of Bleormine Tablet

Add the expiry date on your pack for a full Trust Score.

Ou prenez la boîte en photo
Encore 3 vérifications gratuites aujourd'hui Sources officielles : FDA américaine · EMA (UE) · NAFDAC · alertes OMS

About Bleormine Tablet

What is in Bleormine Tablet?

Bleormine Tablet contains Promethazine Teoclate (25 mg), as tablet, according to its NAFDAC registration record.

Is Bleormine Tablet registered with NAFDAC?

Yes. Bleormine Tablet is listed on the NAFDAC register under registration number B4-5620, and its registration is active as of 29 October 2026.

Has Bleormine Tablet been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Bleormine Tablet in our automatically synced alert list.

How can I check that my pack of Bleormine Tablet is genuine?

Run a free authenticity scan with the NAFDAC number B4-5620, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Bleormine Tablet?

Follow your prescription or the leaflet in your pack. The official label says: Promethazine hydrochloride tablets, USP are contraindicated for children under 2 years of age (see WARNINGS - Black Box Warning and Use in Pediatric Patients ). Promethazine hydrochloride tablets, USP are for oral administration only. Allergy The average oral dose is 25 mg taken before retiring; however, 12.5 mg may be taken before meals and on retiring, if necessary. Single 25…

What is Bleormine Tablet used for?

Promethazine hydrochloride tablets, USP are useful for: Perennial and seasonal allergic rhinitis. Vasomotor rhinitis. Allergic conjunctivitis due to inhalant allergens and foods. Mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Amelioration of allergic reactions to blood or plasma. Dermographism. Anaphylactic reactions, as adjunctive therapy to epinephrine and other st (Summarised from the official U.S. FDA label for promethazine teoclate. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Bleormine Tablet? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.